How we approach transfusions in a patient with high risk of alloimmunization from McLeod phenotype.
McLeod
alloimmunization
chronic granulomatous disease
transfusion
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
revised:
15
10
2022
received:
24
06
2022
accepted:
07
11
2022
pubmed:
11
12
2022
medline:
28
12
2022
entrez:
10
12
2022
Statut:
ppublish
Résumé
McLeod phenotype-caused by the missing Xk protein-is a very rare red cell phenotype, one characteristic of McLeod syndrome, and sometimes associated with X-linked chronic granulomatous disease (CGD). Diagnosis of McLeod phenotype is important for appropriate transfusion management, because red blood cells from all healthy donors will have the Xk protein with its Kx antigen and can lead to red cell antibody formation without the ability to find compatible McLeod phenotype blood for transfusion. We offer a review and approach to diagnosis of the McLeod phenotype and special transfusion considerations.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e30119Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Denomme GA. Kell and Kx blood group systems. Immunohematology. 2015;31:14-19.
Daniels G. Kell and Kx blood group systems. In: Human Blood Groups. 3rd ed. 2013:278-305.
Russo D, Redman C, Lee S. Association of XK and Kell blood group proteins. J Biol Chem. 1998;273:13950-13956.
Khamlichi S, Bailly P, Blanchard D, Goossens D, Cartron JP, Bertrand O. Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients. Eur J Biochem. 1995;228:931-934.
Jung HH, Danek A, Frey BM. McLeod syndrome: a neurohaematological disorder. Vox Sang. 2007;93:112-121.
Walker RH, Danek A, Uttner I, Offner R, Reid M, Lee S. McLeod phenotype without the McLeod syndrome. Transfusion (Paris). 2007;47:299-305.
Lhomme F, Peyrard T, Babinet J, et al. Chronic granulomatous disease with the McLeod phenotype: a French national retrospective case series. J Clin Immunol. 2020;40:752-762.
Bansal I, Jeon HR, Hui SR, et al. Transfusion support for a patient with McLeod phenotype without chronic granulomatous disease and with antibodies to Kx and Km. Vox Sang. 2008;94(3):216-220.
Russo D, Ragnhild O, Vivien P, et al. First example of anti-Kx in a person with the McLeod phenotype and without chronic granulomatous disease. Transfusion (Paris). 2000;40:1371-1375.
Redman CM, Huima T, Robbins E, Lee S, Marsh WL. Effect of phosphatidylserine on the shape of McLeod red cell acanthocytes. Blood. 1989;74:1826-1835.
Beaulieu GP, Ward DC, Panch SR, Flegel WA. Acanthocytes in the McLeod phenotype of X-linked chronic granulomatous disease. Transfusion (Paris). 2017;57:2307-2308.
Cid J, Lozano M, Ziman A, et al. Low frequency of anti-D alloimmunization following D+ platelet transfusion: the anti-D alloimmunization after D-incompatible platelet transfusions (ADAPT) study. Br J Haematol. 2015;168:598-603.
Valentine SL, Bembea MM, Muszynski JA, et al. Consensus recommendations for RBC transfusion practice in critically ill children from the pediatric critical care transfusion and anemia expertise initiative. Pediatr Crit Care Med. 2018;19:884-898.
Go RS, Winters JL, Kay NE. How I treat autoimmune hemolytic anemia. Blood. 2017;129:2971-2979.
Meny GM, Flickinger C, Marcucci C. The American Rare Donor Program. J Crit Care. 2013;28:110.e9-110.e18.
Turner T, Clarke G, Denomme G, Skeate R, Acker J. Effect of cryopreservation on a rare McLeod donor red blood cell concentrate. Immunohematology. 2021;37:78-83.
Tong TN, Cen S, Branch DR. The monocyte monolayer assay: past, present and future. Trans Med Rev. 2019;33:24-28.
Kelly K, Helander L, Hazegh K, et al. Cryopreservation of rare pediatric red blood cells for support following bone marrow transplant. Transfusion. 2022;62(5):954-960.